Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Dis-Chem Pharmacies's Enterprise Value is R34,362 Mil.
Dis-Chem Pharmacies's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was R1,949 Mil. Therefore, Dis-Chem Pharmacies's EV-to-EBIT ratio for today is 17.63.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Dis-Chem Pharmacies's Enterprise Value is R34,362 Mil.
Dis-Chem Pharmacies's EBITDA for the trailing twelve months (TTM) ended in Feb. 2026 was R1,949 Mil. Therefore, Dis-Chem Pharmacies's EV-to-EBITDA ratio for today is 17.63.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Dis-Chem Pharmacies's Enterprise Value is R34,362 Mil.
Dis-Chem Pharmacies's Revenue for the trailing twelve months (TTM) ended in Feb. 2026 was R42,826 Mil. Therefore, Dis-Chem Pharmacies's EV-to-Revenue ratio for today is 0.80.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Dis-Chem Pharmacies (JSE:DCP) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Dis-Chem Pharmacies's current Enterprise Value is R34,362 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dis-Chem Pharmacies's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was R1,949 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Dis-Chem Pharmacies's current Enterprise Value is R34,362 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dis-Chem Pharmacies's EBITDA for the trailing twelve months (TTM) ended in Feb. 2026 was R1,949 Mil.
Dis-Chem Pharmacies's current Enterprise Value is R34,362 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dis-Chem Pharmacies's Revenue for the trailing twelve months (TTM) ended in Feb. 2026 was R42,826 Mil.
Dis-Chem Pharmacies's current Enterprise Value is R34,362 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dis-Chem Pharmacies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2026 was R1,793 Mil.
Dis-Chem Pharmacies's current Enterprise Value is R34,362 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dis-Chem Pharmacies's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2026 was R689 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies Enterprise Value Related Terms
Dis-Chem Pharmacies Enterprise Value Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies Enterprise Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dis-Chem Pharmacies Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Dis-Chem Pharmacies's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Dis-Chem Pharmacies's Enterprise Value for the fiscal year that ended in Feb. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies (JSE:DCP) has a Enterprise Value of R34,362 Mil as of Jul. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Dis-Chem Pharmacies and its competitors.
Is Dis-Chem Pharmacies' Enterprise Value too high?
Dis-Chem Pharmacies' current Enterprise Value is R34,362 Mil. Overall, Dis-Chem Pharmacies has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' Enterprise Value compare to competitors?
Dis-Chem Pharmacies' Enterprise Value of R34,362 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Dis-Chem Pharmacies and its competitors. Dis-Chem Pharmacies's current Enterprise Value is R34,362 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.05, compared to a current price of R32.91 — trading 13.5% below its estimated fair value. The current Enterprise Value is R34,362 Mil. Dis-Chem Pharmacies' overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current Enterprise Value is R34,362 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R32.91 is trading 13.5% below its estimated GF Value™ of R38.05.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
Enterprise Value: R34,362 Mil
GF Value™: R38.05 vs. price of R32.91 (13.5% below fair value)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
87GF Score
Get the complete analysis for JSE:DCP
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
